Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 29, 2026
Coca-Cola (KO) Beats Q2 Estimates with +5% Volume Growth and Raises Full-Year Outlook

Coca-Cola (KO) Beats Q2 Estimates with +5% Volume Growth and Raises Full-Year Outlook

Key Takeaways

  • Coca-Cola exceeded Wall Street estimates in the second quarter of 2026, reporting adjusted earnings of $0.97 per share versus the $0.93 consensus and net revenues of $13.38 billion against expectations of approximately $13.16 billion.
  • Global unit case volume grew 5%, marking a meaningful acceleration driven by FIFA World Cup marketing activation, favorable weather in select markets, and continued strength in Coca-Cola Zero Sugar, which surged 16%.
  • Margins expanded meaningfully, with comparable gross margin improving by approximately 120 basis points to 63.4% and comparable operating margin rising 86 basis points to 35.6%, supported by organic revenue growth and currency tailwinds.
  • Full-year 2026 guidance was raised, with organic revenue growth now expected at approximately 5% (top of prior 4% to 5% range) and comparable EPS (earnings per share) growth lifted to 9% to 10% from the previous 8% to 9%.
  • Shares climbed to an all-time high, rising roughly 6% to 7% on the day of the release, reflecting strong investor approval of the broad-based beat and upwardly revised outlook.

Why This Earnings Report Matters

The Coca-Cola Company's second-quarter report carried heightened significance for several reasons. It marked the second full quarter under new CEO Henrique Braun and offered a fresh look at how the iconic beverage giant is navigating a mixed consumer spending environment. With the stock already up roughly 20% year-to-date heading into the release, investors were watching closely to see whether operational momentum could justify the valuation. The quarter also coincided with the company's high-profile FIFA World Cup 2026 sponsorship, providing a rare large-scale test of marketing-driven volume growth. Strong results would reinforce Coca-Cola's reputation as an all-weather defensive holding and Dividend King, while any miss could raise questions about the sustainability of its premium pricing strategy amid persistent inflationary pressure on lower-income consumers globally.

The Quarter's Reported Results

The Coca-Cola Company (KO) reported net revenues of $13.38 billion for the second quarter ended July 3, 2026, representing a 7% increase from $12.54 billion in the prior-year period and surpassing the consensus analyst estimate of approximately $13.16 billion. Organic revenues, which exclude the impact of currency fluctuations and acquisitions or divestitures, grew 6%, driven by a 4% rise in concentrate sales and 2% growth in price/mix.

On the bottom line, GAAP earnings per share reached $1.03, up 16% from $0.89 a year ago, while comparable (non-GAAP) EPS rose 11% to $0.97, comfortably exceeding the $0.93 Wall Street estimate. Net income attributable to shareholders climbed 16% to $4.43 billion, and operating income rose 9% to $4.67 billion.

Global unit case volume expanded 5%, with growth concentrated in India, China, the United States, and Brazil. Trademark Coca-Cola volume grew 5% across all geographic segments, while Coca-Cola Zero Sugar recorded a standout 16% volume increase. Powerade volume rose 8%, aided by hydration-break visibility during World Cup matches. Sparkling flavors grew 4%, and water, sports, coffee, and tea combined rose 6%.

Comparable gross margin expanded approximately 120 basis points to 63.4%, and comparable operating margin improved 86 basis points to 35.6%. North America led profit growth with a 12% increase in comparable currency-neutral operating income, while the Asia Pacific segment, despite 8% volume growth, saw flat comparable currency-neutral operating income due to a 9% decline in price/mix. I also checked this using Tickeron’s AI Screener to see how KO compares to peers on margin trends.

Market Reaction and Investor Sentiment

Investors responded decisively to Coca-Cola's second-quarter results and revised guidance. Shares surged approximately 6% to 7% in the trading session following the release, touching an all-time high near $90 and pushing year-to-date gains past 25%. The magnitude of the move was notable for a stock typically characterized by low volatility, suggesting the market interpreted the beat as a sign of genuine operational strength rather than a one-time benefit.

Several factors underpinned the bullish reception: the 5% unit case volume growth alleviated concerns that price-led revenue gains were masking weakening demand, while the margin expansion demonstrated effective cost management despite higher input costs and increased marketing investments. The upward revision to full-year guidance further reinforced confidence in management's ability to sustain momentum through the second half. For income-oriented investors, the company's 2.5% dividend yield and 64-year streak of consecutive annual dividend increases continued to bolster the stock's appeal as a defensive anchor within diversified portfolios.

Looking Ahead: Key Factors to Monitor

Looking ahead, Coca-Cola's raised guidance sets a constructive tone for the remainder of fiscal 2026, but several variables will shape the trajectory from here. Management now expects organic revenue growth of approximately 5% and comparable EPS growth of 9% to 10%, with a projected 3% currency tailwind and roughly 1% headwind from acquisitions and divestitures.

One key area to watch is the evolving pricing and volume dynamic across regions. North America continues to deliver balanced growth, with 3% volume growth and 4% price/mix, generating robust profit expansion. However, the Asia Pacific segment presents a more complex picture: strong concentrate sales volume growth of 11% was largely offset by a 9% decline in price/mix, reflecting deliberate affordability investments in markets like India and China. Whether this strategy translates into sustainable value share gains without prolonged margin compression will be an important storyline in coming quarters.

On the cost side, the company noted that it locked in lower input prices for certain commodities before geopolitical disruptions involving Iran escalated earlier in the year. With the conflict ongoing and peer PepsiCo already warning of accelerating input-cost inflation in the second half, investors will closely monitor Coca-Cola's October update for its 2027 cost outlook. Additionally, the fading of FIFA World Cup-related marketing tailwinds in the second half could shift the growth mix back toward underlying brand strength and day-to-day consumer demand rather than event-driven activation.

The performance of Coca-Cola Zero Sugar remains another critical monitor. The 16% volume surge in Q2 suggests the zero-calorie portfolio is resonating strongly, potentially aided by changing consumer health preferences and increased adoption of GLP-1 weight-management medications that may be redirecting demand toward zero-sugar beverages. Sustaining this momentum will require continued innovation, marketing investment, and distribution gains across both developed and emerging markets. From what I see, this dynamic is worth tracking closely with tools like Tickeron’s AI Trend Prediction Engine in future quarters.

Enhancing My Research with Tickeron Tools

In my own process, I often turn to Tickeron’s AI Screener when evaluating earnings momentum and peer comparisons. The platform helps filter thousands of securities using customizable parameters like margins, volume trends, and AI signals, which can streamline identifying stocks with similar characteristics to KO. It has become a practical part of how I cross-check quantitative data alongside traditional analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: KO

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


KO's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for KO moved out of overbought territory on July 30, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 instances where the indicator moved out of the overbought zone. In of the 40 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where KO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

KO broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 28, 2026. You may want to consider a long position or call options on KO as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KO just turned positive on July 28, 2026. Looking at past instances where KO's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KO advanced for three days, in of 335 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 293 cases where KO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. KO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: KO's P/B Ratio (10.341) is slightly higher than the industry average of (5.764). P/E Ratio (26.081) is within average values for comparable stocks, (42.903). Projected Growth (PEG Ratio) (4.184) is also within normal values, averaging (4.589). Dividend Yield (0.024) settles around the average of (0.026) among similar stocks. KO's P/S Ratio (7.474) is slightly higher than the industry average of (2.926).

Notable companies

The most notable companies in this group are Coca-Cola Company (NYSE:KO), PepsiCo (NASDAQ:PEP).

Industry description

Non-alcoholic drinks include traces of alcohol or low alcohol content or without alcohol or alcohol removed. Functional Beverages, Carbonated Soft Drinks (CSDs), Sports Drinks, Fruit Beverages, and Bottled Water are some common types of non-alcoholic beverages. The largest segment in this market is soft drinks (think Pepsi and Coke). Many established companies in this space have also been stepping up production of low to zero-calorie varieties in recent years, to cater to a rising number of health-conscious consumers. Coca-Cola Company, Pepsico Inc, Keurig Dr Pepper Inc. and Monster Beverage Corporation are some major non-alcoholic beverage makers.

Market Cap

The average market capitalization across the Beverages: Non-Alcoholic Industry is 47.26B. The market cap for tickers in the group ranges from 1.77K to 373.68B. KO holds the highest valuation in this group at 373.68B. The lowest valued company is BVNNF at 1.77K.

High and low price notable news

The average weekly price growth across all stocks in the Beverages: Non-Alcoholic Industry was -4%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was -11%. BUDA experienced the highest price growth at 7%, while SUJA experienced the biggest fall at -38%.

Volume

The average weekly volume growth across all stocks in the Beverages: Non-Alcoholic Industry was 78%. For the same stocks of the Industry, the average monthly volume growth was 61% and the average quarterly volume growth was 30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 65
Price Growth Rating: 60
SMR Rating: 61
Profit Risk Rating: 73
Seasonality Score: -32 (-100 ... +100)
View a ticker or compare two or three
KO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of non-alcoholic beverages

Industry BeveragesNonAlcoholic

Profile
Details
Industry
Beverages Non Alcoholic
Address
One Coca-Cola Plaza
Phone
+1 404 676-2121
Employees
79100
Web
https://www.coca-colacompany.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Coca-Cola (KO) Beats Q2 Estimates with +5% Volume Growth and Raises Full-Year Outlook